A woman with malignant bowel obstruction who did not want to die with tubes

Lancet

Volumn 347, Issue 9006, 1996, Pages 944-

  Steadman, K ^a,b   Franks, A ^a  

^a Leicestershire Hospice   (United Kingdom)

^b MOORGREEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

AGED; ARTICLE; CASE REPORT; DYING; FEMALE; HUMAN; INTESTINE OBSTRUCTION; PANCREAS CARCINOMA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TERMINAL CARE;

EID: 13344259981     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)91418-X     Document Type: Article

References (5)

1. Johnson IS. Octreotide and the management of intestinal obstruction. Articles on somatostatin and analogue peptides newsletter No 25, 1994. London: Current Medical Literature Ltd.
2. Baines M. Intestinal obstruction in patients with advanced cancer. Palliative Care Today 1995; IV: 4-6.
3. Mercadante S, Spoldi E, Caraceni A, Maddaloni S, Simonetti MT. Octreotide in relieving gastrointestinal symptoms due to bowel obtruction. Palliative Med 1993; 7: 295-99.
4. Ripamonti C. Malignant bowel obstruction in advanced and terminal cancer patients. Eur J Palliative Care 1994; 1: 1-19.
5. Fallon MT. The physiology of somatostatin and its synthetic analogue, octreotide. Eur J Palliative Care 1994; 1: 20-22.